Biogen · 4 months ago
Associate Director, Contract Strategy- Neuropsychiatry Franchise
Cambridge, MA
Full-time, Contract
Onsite
Senior Level, Lead/Staff, Director/Executive
$168K/yr - $231K/yr
7+ years expBiogen is a mid-sized biotechnology company committed to delivering life-changing medicines. The Associate Director, Contract Strategy for the Neuropsychiatry Franchise will play a key role in developing market access and contracting strategies, focusing on enhancing patient experiences and outcomes in women's health.
BiotechnologyHealth CareNeuroscienceTherapeutics
Responsibilities
Develop and execute national and regional contracting strategies across commercial, government, and specialty pharmacy channels
Monitor competitive landscape and assess contracting trends in women’s health and specialty therapeutics
Lead development of strategies that optimize the patient journey from prescription to appropriate dosing, with emphasis on postpartum clinical needs
Collaborate with medical affairs and HEOR to align dosing strategy with real-world evidence, safety, and outcomes data
Identify barriers to appropriate prescribing and dosing (e.g., coverage gaps, step edits, patient dynamics) and recommend solutions
Partner with commercial distribution and patient support teams to ensure dosing education, patient experience, and provider resources are effectively implemented
Serve as the subject matter expert for contract and dosing strategies, advising senior leadership on market dynamics
Collaborate with sales, marketing, medical, and patient services to integrate access and dosing strategies into brand planning
Support forecasting, scenario planning, and process improvement for the postpartum drug
Qualification
Required
Bachelor's degree required; advanced degree (MBA, MPH, PharmD, or related field) preferred
7+ years of experience in pharmaceutical market access, contracting, pricing, or related commercial functions
Deep understanding of payer dynamics, provider networks, and reimbursement models within specialty or women's health markets
Strong analytical, negotiation, and communication skills
Ability to work in a fast-paced, evolving environment and lead cross-functional initiatives
Preferred
Experience developing Rx-to-dose or patient access strategies for specialty products preferred
Experience launching or managing products with complex Rx to dose pathways
Strategic thinker who can operate both at the tactical and enterprise level
High level of comfort working in a fast-paced, evolving environment
Experience with controlled substances
Benefits
Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation
Company
Biogen
Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.
Founded in 1978Cambridge, Massachusetts, USA
5001-10000 employees
H1B Sponsorship
Biogen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)
Funding
Current Stage
Public CompanyTotal Funding
$1.5BKey Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO
Leadership Team
Robin C. Kramer
Executive Vice President, Chief Financial Officer
Priya Singhal
Executive Vice President, Head of Development
Recent News
2026-01-16
2026-01-16
Company data provided by crunchbase